Post-earnings recap
Reported
Wed, Oct 23, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
Eli Lilly's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock fell by 2.22% in reaction, likely due to the lack of revenue details and guidance. Investors may be cautious as the company navigates market challenges while focusing on its product pipeline.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.48 | N/A | +4.56% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in their long-term strategy but acknowledged current market challenges. They emphasized the need for continued innovation.
Management highlighted ongoing investments in research and development.
They noted the importance of maintaining a strong pipeline of new products.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—